Tech moguls’ “move fast and break things” ethos is a bad fit for chatbots posing catastrophic risks. As security incidents proliferate, regulation becomes inevitable. Pharmaceutical trials offer a template for products promising life-changing benefits, but with heavy uncertainty.
